Evidence map›Paper›PMID 30626422›Full record

ArticleJournal of experimental & clinical cancer research : CR2019

Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage.

Zhangjian Zhou, Heng Lu, Shoumin Zhu, Ahmed Gomaa, Zheng Chen, Jin Yan, Kay Washington, Wael El-Rifai, Chengxue Dang, Dunfa Peng

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The role of bile acids in carcinogenesis.Cellular and molecular life sciences : CMLS · 2022
    Review
  14. Article
  15. Expression and significance of CDX2, FXR, and TGR5 in esophageal cancer.International journal of clinical and experimental pathology · 2022
    Article
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Zhangjian ZhouDepartment of Surgical Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta W. Road, Xi'an, 710061, Shaanxi, China.
Heng LuDepartment of Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136-1015, USA.
Shoumin ZhuDepartment of Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136-1015, USA.
Ahmed GomaaDepartment of Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136-1015, USA.
Zheng ChenDepartment of Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136-1015, USA.
Jin YanDepartment of Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136-1015, USA.
Kay WashingtonDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Wael El-RifaiDepartment of Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136-1015, USA.
Chengxue DangDepartment of Surgical Oncology, the First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta W. Road, Xi'an, 710061, Shaanxi, China. dangchengxue@mail.xjtu.edu.cn.
Dunfa PengDepartment of Surgery, University of Miami Miller School of Medicine, Miami, FL, 33136-1015, USA. dunfa.peng@med.miami.edu.ORCID http://orcid.org/0000-0002-2182-7221
University of Miami · USFirst Affiliated Hospital of Xi'an Jiaotong University · CNVanderbilt University Medical Center · US

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal CancerP50CA236733 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STEPHEN W. FESIK · 2019 to 2026
$19.6M
The Molecular Functions of APE1 in Barrett's TumorigenesisR01CA206563 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI EL-RIFAI, WAEL · 2015 to 2020
$2.2M
The role of NRF2 in reflux-induced esophageal adenocarcinomasR01CA224366 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI EL-RIFAI, WAEL · 2018 to 2022
$1.7M
Molecular Pathobiology of Gastric CarcinogenesisI01BX001179 · VA · VETERANS HEALTH ADMINISTRATION · PI EL-RIFAI, WAEL · 2012 to 2024
–
BLRD Research Career Scientist Award ApplicationIK6BX003787 · VA · VETERANS HEALTH ADMINISTRATION · PI WAEL EL-RIFAI · 2017 to 2026
–
BLRD VA I01 BX001179BLRD VA IK6 BX003787Foundation for the National Institutes of Health R01CA206563Foundation for the National Institutes of Health R01CA224366NCI NIH HHS P50 CA236733NCI NIH HHS R01 CA206563NCI NIH HHS R01 CA224366NIDDK NIH HHS P30 DK058404Sylvester Comprehensive Cancer Center development fundsU.S. Department of Veterans Affairs 1IK6BX003787U.S. Department of Veterans Affairs I01BX001179
6 · The paper itself

Abstract

backgroundThe incidence of esophageal adenocarcinoma (EAC) is rising rapidly in the US and Western countries. The development of Barrett's esophagus (BE) and its progression to EAC have been linked to chronic gastroesophageal reflux disease (GERD). Exposure of BE and EAC cells to acidic bile salts (ABS) in GERD conditions induces high levels of oxidative stress and DNA damage. In this study, we investigated the role of insulin-like growth factor binding protein 2 (IGFBP2) in regulating ABS-induced DNA double-strand breaks.

methodsReal-time RT-PCR, western blot, immunohistochemistry, immunofluorescence, co-immunoprecipitation, flow cytometry, and cycloheximide (CHX) chase assays were used in this study. To mimic GERD conditions, a cocktail of acidic bile salts (pH 4) was used in 2D and 3D organotypic culture models. Overexpression and knockdown of IGFBP2 in EAC cells were established to examine the functional and mechanistic roles of IGFBP2 in ABS-induced DNA damage.

resultsOur results demonstrated high levels of IGFBP2 mRNA and protein in EAC cell lines as compared to precancerous Barrett's cell lines, and IGFBP2 is frequently overexpressed in EACs (31/57). Treatment of EAC cells with ABS, to mimic GERD conditions, induced high levels of IGFBP2 expression. Knocking down endogenous IGFBP2 in FLO1 cells (with constitutive high levels of IGFBP2) led to a significant increase in DNA double-strand breaks and apoptosis, following transient exposure to ABS. On the other hand, overexpression of exogenous IGFBP2 in OE33 cells (with low endogenous levels of IGFBP2) had a protective effect against ABS-induced double-strand breaks and apoptosis. We found that IGFBP2 is required for ABS-induced nuclear accumulation and phosphorylation of EGFR and DNA-PKcs, which are necessary for DNA damage repair activity. Using co-immunoprecipitation assay, we detected co-localization of IGFBP2 with EGFR and DNA-PKcs, following acidic bile salts treatment. We further demonstrated, using cycloheximide chase assay, that IGFBP2 promotes EGFR protein stability in response to ABS exposure.

conclusionsIGFBP2 protects EAC cells against ABS-induced DNA damage and apoptosis through stabilization and activation of EGFR - DNA-PKcs signaling axis.

Indexed as

DNA DamageSignal TransductionAdenocarcinomaApoptosisBile Acids and SaltsCell Line, TumorDNA-Activated Protein KinaseDNA Breaks, Double-StrandedErbB ReceptorsEsophageal NeoplasmsGene Expression Regulation, NeoplasticHumansInsulin-Like Growth Factor Binding Protein 2Models, BiologicalMultiprotein ComplexesNuclear ProteinsBile Acids and SaltsDNA-Activated Protein KinaseEGFR protein, humanErbB ReceptorsInsulin-Like Growth Factor Binding Protein 2Multiprotein ComplexesNuclear ProteinsPRKDC protein, humanAcidic bile saltsDNA damageDNA-PKcsEGFREsophageal adenocarcinomaIGFBP2

Identifiers

PMID30626422
PMCPMC6327430
OpenAlexW2910035171

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.